2024 perioperative management glp-1 receptor agonists anesthesia Anesthetic Considerations for Patients Taking Glucagon-Like Peptide-1 Perioperative management of patients taking

Among the marketed large molecule injectable GLP-1 agonists, semaglutide, apart from weight-loss, is being studied for kidney disease and tirzepatide (a dual GLP-1 and GIP receptor agonist) is being evaluated for sleep apnea in Ph 3 clinical trials

Explore GLP-1 medications like Ozempic and Wegovy

Glucagon-like peptide-1 (GLP-1) is a hormone involved in glucose homeostasis and satiety regulation

However, there was progress in the UK where the government announced Scotland CardioMetabolic Impact Study (SCoMIS) , a pioneering Real-World study, which will provide Wegovy to between 3,000-5,000 people living with Obesity in Scotlands poorest areas free of charge during a three year study [11] Despite FDA phasing out enforcement discretion that allowed GLP-1 compounding during shortages - and setting May 2025 deadlines for compounding to cease - compounding has continued beyond this deadline [12]